The utility of drug checking services as monitoring tools and more: A response to Pirona et al. is a response to the article titled New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe by Pirona et al. It argues that although it’s important to recognise the limitations of self-evaluation of drug checking services conducted in a constrained funding environment, we believe that a more balanced view of these services could better inform readers of the International Journal of Drug Policy.
ResearchTags
2C-B 2C-X alcohol alprazolam amphetamine anxiety benzodiacepine bipolar buprenorphine bupropion cannabis cocaine depression DMT drug checking service drug testing ecstasy fentanyl GBL GHB heroin isotretinoin ketamine lidocaine LSD MDMA memory mephedrone methadone methamphetamine methylone methylphenidate morphine mushroom NBOME NPS opiates opium oxandrolone oxycodone schizophrenia speed steroids testosterone tramadol
Recent posts
- Important information about shipments 24 December, 2021
- Recent Adware Attack on site 16 December, 2020
- Back in Business & Overhaul 4 June, 2020
- Drug Crypto Markets at CND63 27 March, 2020
- Update regarding COVID-19 23 March, 2020
- Delays with our HPLC analyses 13 February, 2020